Supercharging the ECG: AI set to Revolutionise the Diagnostic Cardiology Market

Signify Research has just released a deep-dive qualitative analysis of developments around the use of AI to analyse and interpret electrocardiograms (ECGs), one of the world’s most ubiquitous diagnostic tests for cardiac disease.

Supercharging the ECG: AI set to Revolutionise the Diagnostic Cardiology Market – Signify Research

Recent Post

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
HeartSciences Bets Big on AI Amid Surging Heart Disease Deaths
New study reveals HeartSciences’ MyoVista as a breakthrough in cardiac screening
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
View All HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes
Journal Article: Use of the energy waveform electrocardiogram to detect subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus
View All HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology
Today Show highlights that AI-ECG is set to change medicine and save lives.
How AI is Reshaping Diagnostic Tools
HeartSciences Appoints New Scientific Advisory Board Member